CBX2 mRNA high expression was correlated to shorter RFS in BC patients with lymph node-positive tumors (HR=2.11, p=7.7e-09) (Figure 4F), but not in node-negative tumors (HR=1.42, p=0.7) (Figure 4G). Here, CBX2 is linked to breast cancer.